Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection.

Saved in:
Bibliographic Details
Title: Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection.
Authors: Li R; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Hensley PJ; Department of Urology, University of Kentucky College of Medicine, Lexington, KY, USA., Gupta S; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Al-Ahmadie H; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Babjuk M; Department of Urology, Second Faculty of Medicine of Charles University, University Hospital Motol, Prague, Czechia., Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, Canada., Brausi M; Department of Urology, Hesperia Hospital, Modena, Italy., Bree KK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fernández MI; Department of Urology, Clinica Alemana Universidad del Desarrollo, Santiago, Chile., Guo CC; Department of Genitourinary Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Horowitz A; Departments of Immunology & Immunotherapy and Oncological Sciences, Lipschultz Precision Immunology Institute and The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Lamm DL; BCG Oncology PC, University of Arizona College of Medicine, Phoenix, AZ. USA., Lerner SP; Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA., Lotan Y; Department of Urology, UT Southwestern Medical Center, Dallas, TV, USA., Mariappan P; Edinburgh Bladder Cancer Surgery, University of Edinburgh, Department of Urology, Western General Hospital, Edinburgh, UK., McConkey D; Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA., Mertens LS; Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Mir C; Department of Urology, Hospital Universitario La Ribera, Valencia, Spain., Ross JS; Upstate Medical University, Syracuse, NY, USA; Foundation Medicine, Boston, MA USA., O'Donnell M; Carver College of Medicine, University of Iowa, Iowa City, IA, USA., Palou J; Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Pohar K; Department of Urology, Ohio State University, Columbus, OH, USA., Steinberg G; Department of Urology, Rush University Medical Center, Chicago, IL, USA., Soloway M; Memorial Hospital, Hollywood, FL, USA., Spiess PE; Moffitt Cancer Center, Morsani College of Medicine, University of South Florida Tampa, FL, USA., Svatek RS; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA., Tan WS; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Taoka R; Faculty of Medicine, Kagawa University, Kagawa, Japan., Buckley R; North York General Hospital, Toronto, Canada., Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: akamat@mdanderson.org.
Source: European urology [Eur Urol] 2024 Dec; Vol. 86 (6), pp. 516-527. Date of Electronic Publication: 2024 Aug 24.
Publication Type: Journal Article; Practice Guideline; Review
Journal Info: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-7560
DOI:10.1016/j.eururo.2024.08.001